Anne Grahl

Anne Grahl is an analyst at Pureos Bioventures. Anne has also worked as an investment analyst at M Ventures and as a collaborator at i&i Prague. Anne has a Ph.D. in structural and biophysical characterisation of GPCR mutants for ligand affinity and efficacy from the University of Basel.

Anne Grahl has a PhD in Structural Biology from the Biozentrum at the University of Basel. Anne also has an MS in Biochemistry and Molecular Biology from Kiel University, and a BS in Biochemistry and Molecular Biology from Friedrich Schiller University Jena. Additionally, they participated in an Erasmus program in Biochemistry at the University of York.